Evolution of the Average Target: Indivior Pharmaceuticals, Inc.

Evolution of the Target Price: Indivior Pharmaceuticals, Inc.

Changes in Analyst Recommendations: Indivior Pharmaceuticals, Inc.

62f963aac0a7e24458c1075d79ab.m3_H8vo3bL3vCPXSWK3VMr8CEtf_PrLn5PmIgqtl6Qw.qgudy5ECBIigbYC7M9-YQuw6db29DNWPlY__r5wk20faDKy6k3kf2KtqtA~84a66be381baa0c8c8459060085575bd

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+11.96%
+1.66%
+8.26%
+3.24%
+0.76%
+31.03%
-10.16%
+4.82%
+8.05%
Average +6.62%
Weighted average by Cap. +7.26%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
34.87USD
Average target price
49.00USD
Spread / Average Target
+40.52%
High Price Target
53.00USD
Spread / Highest target
+51.99%
Low Price Target
43.00USD
Spread / Lowest Target
+23.32%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. INDV Stock
  4. E7P Stock
  5. Consensus Indivior Pharmaceuticals, Inc.